Company Data

NervGen Pharma Corp

Ticker
NGENF
Current Price
$1.89
Market Cap
$132.6M
Price Target
Refer to Report
Volume
5.4K
52wk Range
$1.16 - $2.99
Advanced Market Data

Overview

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer’s disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy